Filter Results :

Your search for inhibitors returned 473 reports

Sort by


Cancer Growth Inhibitors Market & Clinical Pipeline Analysis

08 Apr 2015  |  Published by:  KuicK Research
Pharmaceutical industry consists of various products for cancer treatment and several years of research along with significant investments have helped in developing many innovative products. Every year, new cancer therapeutic belonging to different drug category is introduced across the globe....

$ 2,400.00

Read More

Tyrosine Kinase Inhibitors Market & Pipeline Insight 2015

02 Apr 2015  |  Published by:  KuicK Research
Tyrosine kinase is a sub class of Protein Kinases family of enzyme responsible for phosphorylation.It has been found that mutation or other anomaly in these enzymes causes uncontrolled cell division leading to cancer. Because of their direct involvement in cell division they are used in cancer...

$ 2,400.00

Read More

Oncogene Inhibitors Therapy Market & Pipeline Insight 2015

02 Apr 2015  |  Published by:  KuicK Research
Oncogenomics is an emerging field that involves screening of genes that may be involved in cancer development. Human genome consists of 23 chromosomal pairs, approximately 20,000- 25,000 genes and 3,234.83 Mb genome size. Oncogene addiction is a phenomenon in which cancer could be checked by d...

$ 2,400.00

Read More

Insulin Like Growth Factor 2 (IGF-2) Inhibitors -Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
Summary Insulin Like Growth Factor 2 (IGF-2) Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Insulin Like Growth Factor 2 (IGF-2) Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, ...

$ 1,250.00

Read More

Wee1 Tyrosine Kinase inhibitors -Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
Summary Wee1 Tyrosine Kinase inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Wee1 Tyrosine Kinase inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-l...

$ 1,250.00

Read More

Integrase Inhibitors -Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
Summary Integrase Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Integrase Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licen...

$ 1,250.00

Read More

Insulin Like Growth Factor (IGF) Inhibitors -Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
Summary Insulin Like Growth Factor (IGF) Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Insulin Like Growth Factor (IGF) Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technolo...

$ 1,250.00

Read More

The 2016-2021 World Outlook for Scale Inhibitors

01 Apr 2015  |  Published by:  Icon Group International, Inc
This econometric study covers the world outlook for scale inhibitors across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is...

$ 995.00

Read More

The 2016-2021 World Outlook for Corrosion Inhibitors

01 Apr 2015  |  Published by:  Icon Group International, Inc
This econometric study covers the world outlook for corrosion inhibitors across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the countr...

$ 995.00

Read More

Yes Tyrosine Kinase Inhibitors -Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
Summary Yes Tyrosine Kinase Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Yes Tyrosine Kinase Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-lic...

$ 1,250.00

Read More

Interleukin-1 (IL-1) Inhibitors -Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
Summary Interleukin-1 (IL-1) Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Interleukin-1 (IL-1) Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-l...

$ 1,250.00

Read More

Xanthine Oxidase Inhibitors -Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
Summary Xanthine Oxidase Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Xanthine Oxidase Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing...

$ 1,250.00

Read More

Interleukin (IL) Inhibitors -Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
Summary Interleukin (IL) Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Interleukin (IL) Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing...

$ 1,250.00

Read More

Wnt Signaling Pathway Inhibitors -Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
Summary Wnt Signaling Pathway Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Wnt Signaling Pathway Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in...

$ 1,250.00

Read More

Integrin Alpha4beta1/Very Late Antigen-4 (VLA-4) Inhibitors -Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
Summary Integrin Alpha4beta1/Very Late Antigen-4 (VLA-4) Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Integrin Alpha4beta1/Very Late Antigen-4 (VLA-4) Inhibitors. The main objective of this report to track competitor pipeline molecules, relat...

$ 1,250.00

Read More
Total 473 records.